Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Aug 15;11:7739–7749. doi: 10.2147/CMAR.S207801

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2019 Huang et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

NNT-AS1 knockdown suppressed tumor growth in vivo.

Notes: (A) Tumors established with the mice in the sh-NC or sh-NNT-AS1 group. (B) Tumors collected from mice were exhibited. (C) Tumor volume curve of mice injected with CCLP1 cells transfected with sh-NC and sh-NNT-AS1 was analyzed. (D) Tumor weight of mice was measured. (E) Summary of the mechanism of NNT-AS1/miR-485/BCL9 pathway in CCA. The error bars in all graphs represented SD. **p<0.01.

Abbreviations: NC, negative control; NNT-AS1, nicotinamide nucleotide transhydrogenase antisense RNA 1; CCA, cholangiocarcinoma.